Hybrigenics SA
Provider of technologies for studying molecular interactions and antibody selection.
ALHYG | PA
Overview
Corporate Details
- ISIN(s):
- FR0004153930
- LEI:
- 9695003KQD0XMJYDX764
- Country:
- France
- Address:
- 850 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN
Description
Hybrigenics Services is a specialized provider of technologies for studying molecular interactions. Its core offering is the ULTImate Y2H™ platform, a comprehensive Yeast Two-Hybrid system used to discover protein-protein interactions, as well as interactions with DNA, RNA, and small molecules. This technology is applied to drug discovery for target deconvolution and identifying molecular glues. A second key service is the Hybribody platform, which leverages a proprietary synthetic library for the custom selection, validation, and optimization of single-domain antibodies (VHHs/Nanobodies). The company serves clients in fundamental research, pharmaceutical R&D, and agroscience.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-02-08 08:35 |
Le groupe familial ANSEL entre au capital d'Hybrigenics
|
French | 238.4 KB | ||
| 2022-12-05 08:00 |
Hybrigenics dévoile les objectifs de son plan stratégique : 60 M EUR de chiffre…
|
French | 206.2 KB | ||
| 2022-11-16 18:00 |
Visioconférence destinée aux actionnaires d'Hybrigenics et à tous les investiss…
|
French | 208.7 KB | ||
| 2022-11-07 18:00 |
Hybrigenics présentera le 30 novembre 2022 son plan stratégique visant à dévelo…
|
French | 209.4 KB | ||
| 2022-11-02 18:00 |
Résultats semestriels 2022
|
French | 159.9 KB | ||
| 2022-10-21 08:45 |
Signature d'un protocole d'accord en vue d'organiser la cession du bloc de titr…
|
French | 176.9 KB | ||
| 2022-09-19 18:00 |
Hybrigenics confie à Inoviem Scientific le développement de sa molécule pour le…
|
French | 189.3 KB | ||
| 2022-06-27 17:45 |
Stemcis obtient l'autorisation de la FDA pour la commercialisation de ses dispo…
|
French | 213.3 KB | ||
| 2022-06-07 18:00 |
Accord de distribution aux Etats-Unis
|
French | 233.1 KB | ||
| 2022-05-31 18:00 |
Stemcis conclut un partenariat stratégique pour la formation au protocole d'art…
|
French | 195.7 KB | ||
| 2022-04-29 19:05 |
Résultats annuels 2021
|
French | 280.8 KB | ||
| 2022-04-06 18:00 |
Obtention du marquage CE et lancement de la commercialisation du nouveau dispos…
|
French | 201.0 KB | ||
| 2022-04-04 18:00 |
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 190.1 KB | ||
| 2022-01-06 18:30 |
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 191.0 KB | ||
| 2022-01-06 18:00 |
Nomination de Léone Atayi à la Direction générale d'Hybrigenics
|
French | 240.8 KB |
Automate Your Workflow. Get a real-time feed of all Hybrigenics SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Hybrigenics SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Hybrigenics SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
